139 related articles for article (PubMed ID: 3934448)
1. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
2. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
Teicher BA; Crawford JM; Holden SA; Cathcart KN
Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
[TBL] [Abstract][Full Text] [Related]
3. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
4. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Teicher BA; Holden SA; Jacobs JL
Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
[TBL] [Abstract][Full Text] [Related]
5. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
Teicher BA; Holden SA
Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
[TBL] [Abstract][Full Text] [Related]
6. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
Teicher BA; Holden SA; Cathcart KN; Herman TS
J Natl Cancer Inst; 1988 Jun; 80(8):599-603. PubMed ID: 2453675
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Teicher BA; Bernal SD; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
[TBL] [Abstract][Full Text] [Related]
8. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
Teicher BA; Holden SA; Rose CM
Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
[TBL] [Abstract][Full Text] [Related]
9. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
Teicher BA; Holden SA; al-Achi A; Herman TS
Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
[TBL] [Abstract][Full Text] [Related]
10. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
Teicher BA; Herman TS; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
[TBL] [Abstract][Full Text] [Related]
11. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
[TBL] [Abstract][Full Text] [Related]
12. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
13. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
Teicher BA; Holden SA; Rose CM
Int J Cancer; 1985 Nov; 36(5):585-9. PubMed ID: 3932225
[TBL] [Abstract][Full Text] [Related]
14. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
15. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
16. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
17. Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide.
Teicher BA; Waxman DJ; Holden SA; Wang YY; Clarke L; Alvarez Sotomayor E; Jones SM; Frei E
Cancer Res; 1989 Sep; 49(18):4996-5001. PubMed ID: 2504483
[TBL] [Abstract][Full Text] [Related]
18. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of murine tumors by Fluosol-DA 20%.
Lee I; Levitt SH; Song CW
Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]